Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal recognition particle 68kDa pseudogene 1 (SRP68P1) is a non-protein-coding gene (pseudogene) found in humans, located in the chromosomal region associated with Smith-Magenis syndrome on 17p11.2. Unlike the functional SRP68 gene, which encodes part of the signal recognition particle essential for protein targeting to the endoplasmic reticulum, SRP68P1 does not produce a functional protein and has no established role in disease or therapy. Its presence reflects a genomic duplication event but does not correspond to any known biological activity, pathological implication, or pharmacological relevance. SRP68P1 is best regarded as a pseudogene, not a therapeutic target. Its nomenclature and associations reflect its location within the Smith-Magenis syndrome critical region, but it is not functionally involved in the syndrome or other biological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal recognition particle 68kDa pseudogene 1 (SRP68P1).